M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps

Ying Zhu1,2,3, Xiwen Sun1,2,3, Shaolin Tan1,2,3

  • 1Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in Immunology
|December 5, 2022
PubMed
Abstract

Insights

This study identifies key M2 macrophage biomarkers for chronic rhinosinusitis with nasal polyps (CRSwNP). These findings offer insights into CRSwNP pathogenesis and potential therapeutic targets.

Area of Science:

  • Immunology
  • Genomics
  • Bioinformatics

Background:

  • Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous inflammatory disorder.
  • M2 macrophages are implicated in CRSwNP pathogenesis, but mechanisms are unclear.
  • This study aimed to find M2 macrophage-related biomarkers in CRSwNP.

Purpose of the Study:

  • Identify potential biomarkers associated with M2 macrophages in CRSwNP.
  • Elucidate the role of M2 macrophages in the disease's inflammatory pathways.
  • Discover novel therapeutic targets for CRSwNP.

Main Methods:

  • Integrated gene expression datasets (GSE136825, GSE179265) from the GEO database.
  • Applied CIBERSORT and WGCNA to identify M2 macrophage-related gene modules.
  • Utilized DEG analysis, GO/KEGG enrichment, PPI networks, and qRT-PCR for validation.

Main Results:

  • Identified 92 M2 macrophage-associated DEGs.
  • Enrichment analyses showed involvement in immune responses and extracellular matrix.
  • Discovered 18 hub genes, with 18 validated as potential CRSwNP biomarkers (e.g., AIF1, CD163, CSF1R).

Conclusions:

  • Identified novel M2 macrophage-related hub genes crucial for CRSwNP pathogenesis.
  • These biomarkers provide insights into disease mechanisms.
  • Further research on these genes may lead to new treatment strategies for CRSwNP.